NCT01979393 - IRCI Gynae Sarcomas, High Grade Uterine Sarcoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

May 18, 2022

Study Completion Date

January 15, 2024

Conditions

Uterine Sarcoma

Interventions

DRUG

Cabozantinib

DRUG

Placebo

Trial Locations (15)

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

28040

Hospital Universitario San Carlos, Madrid

33076

Institut Bergonie, Bordeaux

69373

Centre Leon Berard, Lyon

Unknown

Institut Bergonie, Bordeaux

Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Nantes

Cambridge University Hospital NHS - Addenbrookes Hospital, Cambridge

NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital, Glasgow

Leeds Teaching Hospitals NHS Trust - St. James's University Hospital, Leeds

Royal Marsden Hospital, London

University College London Hospitals NHS Foundation Trust - University College Hospital, London

Nottingham University Hospitals NHS Trust - City Hospital, Nottingham

Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford

1105 AZ

Academisch Medisch Centrum at University of Amsterdam, Amsterdam

08035

Hospital General Vall D'Hebron, Barcelona

All Listed Sponsors

collaborator

Gynecologic Oncology Group

NETWORK

collaborator

NHS Greater Glasgow and Clyde

OTHER

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK